Moleculin Biotech
| Region | Nordamerika |
| ISIN | US60855D1019 |
| Sektor | Biotechnologie |
| Website | http://www.moleculin.com/ |
Moleculin Biotech is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center, the world’s largest cancer research facility headquartered within the world’s largest medical center.
| Titel | Datum |
|---|---|
| Bumi Armada, MISC, Zetrix, Heitech Padu, Kelington, Kim Hin, Hibiscus, Johor Plantations Group, Ajiya, Pekat, Kimlun, Jiankun & Farm Price | vor ungefähr einem Monat |
| MISC, Bumi Armada call off merger proposal | vor ungefähr einem Monat |
| DNV awards GASA approval to joint LCO2 carrier design by MOL, MISC, PETRONAS CCS Ventures and SDARI | vor ungefähr einem Monat |
| MOL, MISC and PETRONAS form joint venture to advance cross-border CO2 transportation | vor ungefähr 3 Monaten |
| Petronas, MISC and MOL debut LCO2 carrier JV | vor ungefähr 3 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Minori Solutions (1 Artikel) | |
| Microsoft (1 Artikel) | |
| Moovly Media (1 Artikel) | |
| MorphoSys (1 Artikel) | |
| Alle anzeigen | |